DIRS.INFO The most relevant business & tech news

Cisco Systems (CSCO.O) gained 4.6% after the networking equipment maker's fourth-quarter results beat estimates, and its CEO talked up artificial intelligence opportunities. The S&P 500 health sector (.SPXHC), down 0.2%, was among the few major sectors in the red. Advancing issues outnumbered decliners by a 1.91-to-1 ratio on the NYSE and by a 1.16-to-1 ratio on the Nasdaq. The S&P index recorded one new 52-week high and 12 new lows, while the Nasdaq recorded 11 new highs and 95 new lows. Reporting by Amruta Khandekar and Shristi Achar A in Bengaluru Editing by Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.

Persons: Carlo Allegri, Dow, Thomas Martin, Amruta Khandekar, Vinay Dwivedi Organizations: New York Stock Exchange, REUTERS, Cisco, Dow, Nasdaq, U.S, U.S . Federal, Cisco Systems, Globalt Investments, Traders, Fed, Walmart, Target, CVS Health Corp, . Energy, Dow Jones, Ball Corp, BAE Systems, NYSE, Thomson Locations: New York, U.S ., U.S, Bengaluru

☆ Progressive had a great quarter, but it's not Jim Cramer's top insurance stock
▼ + stars: | 2023-08-16 | by ( Morgan Chittum | ) www.cnbc.com time to read: +1 min

CNBC's Jim Cramer says that although Progressive had an "incredible quarter," he prefers Chubb (CB) as a insurance pick. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: CNBC's Jim Cramer, Chubb, Cramer, Jim Cramer's, Jim Cramer, Jim Organizations: Progressive Corp, MetLife, UnitedHealth, Progressive, Federal Reserve, Jim Cramer's Charitable, CNBC

☆ Viking Global slashes Amazon and insurance positions, adds to bets in biotech
▼ + stars: | 2023-08-15 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Ole Andreas Halvorsen's Viking Global hedge fund slashed its holding in Amazon in the second quarter and stepped up bets in biotech, according to the latest 13F filing with the U.S. Securities and Exchange Commission . The so-called Tiger Cub's entirely new positions included a $78 million stake in Alibaba , $6.5 million in C3.ai and $132 million worth of chipmaker Nvidia . Viking Global also cut investments in the CSX railroad nearly 42%. Elsewhere, Viking Global purchased $278 million worth of Netflix stock in the second quarter and opened a $159 million position in shipping giant UPS . Viking Global managed about $24 billion in 13F securities at the end of the second quarter, according to WhaleWisdom.com .

Persons: Ole Andreas Halvorsen's, Halvorsen, Julian Robertson, Jack Dorsey's Block, Phillip Morris, Philip Morris Organizations: Ole Andreas Halvorsen's Viking Global, U.S . Securities, Exchange Commission, Viking Global, Tiger Management, Nvidia, Viking, CSX, TJX, Meta, Netflix, UPS, Chubb Limited, Tenet Healthcare, General Electric, UnitedHealth Group, Constellation Energy, GE Locations: Ole Andreas Halvorsen's Viking, Alibaba, Viking, Progressive

☆ A hedge fund manager shares 2 ChatGPT prompts and the AI plugin he used to filter top stock picks
▼ + stars: | 2023-08-12 | by ( Laila Maidan | ) www.businessinsider.com time to read: +9 min

He fed the LLM data from a terminal and asked it to filter its findings through top academic literature and fund managers. Building on the knowledgeIn his earlier experiments, Patel and his team manually pasted increments of stock data into ChatGPT's text box. Using Julius AI, Patel was able to input data for over 6,800 stocks to see if the outcomes or accuracy would change. The metrics Patel chose to input were based on company fundamentals that he felt were important when picking stocks. Patel concluded that whether it's a human analyst or AI that's picking stocks, there are no guarantees in the stock market.

Persons: Alpesh Patel, it's, Patel, Julius AI, Julius, Price, ChatGPT's, Warren Buffett, Cisco Systems Inc Patel, Johnson, Eli Lilly, Rahul Sonwalkar, you've Organizations: NYSE, Nasdaq, US Securities and Exchange Commission, FTSE, New York Stock Exchange, Alpha, Broadcom, Cisco Systems Inc, Apple Inc UnitedHealth, Johnson, Johnson Exxon Mobil Corp Visa Inc Tesla, Walmart, Taiwan Semiconductor Manufacturing Procter, Gamble, Chevron Corp Mastercard, Depot Inc, Pfizer, AbbVie Inc Merck, Co Inc, Cola Co, Pepsico, Broadcom Inc Alibaba

☆ Insight: What happens when a $2 million gene therapy is not enough
▼ + stars: | 2023-08-12 | by ( Deena Beasley | ) www.reuters.com time to read: +13 min

Their experience raises broader questions around other high-cost gene therapies coming to market, sometimes after accelerated regulatory approvals, drug pricing experts said. Gene therapies work by replacing genes – the body's blueprint for its development. The gene Zolgensma delivers instructs the body to make a protein vital for muscle control. If gene therapies do fall short, it becomes harder to justify prices that researchers have argued are already poor value. More recently, the first hemophilia gene therapy approved by the U.S. Food and Drug Administration was priced by CSL Behring at $3.5 million; 26 more gene therapies are in late-stage development, according to IQVIA.

Persons: Elizabeth Kutschke, Ben, Zolgensma, Ben Kutschke, neurologists, Sitra Tauscher, Wisniewski, Ben's, Roger Hajjar, Brigham Gene, Kutschke, Vasant Narasimhan, Stacie Dusetzina, Roche's, Biogen, Roche, Maha Radhakrishnan, Steven Pearson, It's, Sree Chaguturu, Amanda Cook, Weston, Jackson, Cook, Elizabeth, Jerry Mendell, Russell Butterfield, –, Biogen's, Mendell, UMR, Spinraza, Eric Cox, Caroline Humer, Sara Ledwith Organizations: Reuters, U.S, Novartis, IQVIA Institute, Human Data, Novartis Gene Therapies, Mass, Cell Therapy, U.S . Food, Drug Administration, CSL Behring, CSL, Nashville's Vanderbilt University School of Medicine, Clinical, Economic, CVS Health, Aetna, SMA, Nationwide Children's Hospital, University of Utah Health, Children's, UnitedHealth, Thomson Locations: Oak Park, Berwyn , Illinois, Swiss, U.S, Lebanon , Virginia, United States, Columbus , Ohio, Russia, Kazakhstan, Chicago

☆ Final Trades: American Express, UnitedHealth & more
▼ + stars: | 2023-08-11 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: American Express, UnitedHealth & moreThe "Halftime Report" traders give their top picks to watch for the second half.

Organizations: American Express

☆ ICE cuts tortuous path through frosty trustbusters
▼ + stars: | 2023-08-07 | by ( Jonathan Guilford | ) www.reuters.com time to read: +4 min

A screen displays the logo for Black Knight on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2022. The U.S. Federal Trade Commission agreed on Monday to drop a lawsuit against Intercontinental Exchange’s (ICE.N) $11.7 billion acquisition of mortgage technology provider Black Knight (BKI.N). ICE, as the New York Stock Exchange operator is known, said in May 2022 that it would snap up Black Knight for $13.1 billion. ICE’s Encompass processes nearly half of originations in the United States, with Black Knight’s Empower in second place, according to the FTC. ICE originally said on May 4, 2022, that it had agreed to buy Black Knight for $13.1 billion.

Persons: Knight, Brendan McDermid, Black, Lina Khan, Khan, litigate, Black Knight, Jeffrey Goldfarb, Oliver Taslic Organizations: New York Stock Exchange, REUTERS, Reuters, U.S . Federal Trade Commission, Intercontinental, Black, FTC, ICE, UnitedHealth, Change Healthcare, Exchange, Constellation Software, Thomson Locations: New York City, U.S, United States

☆ Buy these high-quality stocks as macro backdrop remains uncertain, Bernstein says
▼ + stars: | 2023-08-03 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Amid an unpredictable macro environment, quality stocks are well-positioned to outperform, according to Bernstein. "High Quality stocks are attractive against an uncertain macro backdrop. She added that quality stocks trading at a reasonable price perform similarly to quality shares unfiltered for valuation. Given this backdrop, Bernstein compiled a list of stocks that meet its quality at a reasonable price basket. Despite the strong tech rally in 2023, Microsoft and Meta made the list of quality stocks trading at a reasonable price.

Persons: Bernstein, Sarah McCarthy, McCarthy, Morgan Stanley, — CNBC's Michael Bloom Organizations: Microsoft, Meta, UnitedHealth

☆ Humana calms Wall Street's jitters with quarterly results, clearing way for stock to run higher
▼ + stars: | 2023-08-02 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +5 min

Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Not only did second-quarter numbers top expectations, but management offered assuring commentary on the worrisome medical-cost trends that torpedoed its stock price in mid-June . That one-two punch explains the more-than-5% jump in Humana shares, pushing the stock to its highest levels since June 14. Outlook Humana raised its outlook for 2023 individual Medicare Advantage membership growth by 50,000 to roughly 825,000 members, representing an 18% increase compared with enrollment levels at the end of 2022. Capital allocation Humana CFO Susan Diamond said the company has capitalized on the "recent dislocation" in its stock price — i.e.

Persons: MLR —, Wall, Bruce Broussard, —, Broussard, Susan Diamond, Humana, Jim Cramer's, Jim Cramer, Jim, Ty Wright Organizations: Revenue, Humana, Club, UnitedHealth, Management, Insurance, CNBC, Bloomberg, Getty Locations: Louisville , Kentucky

☆ Humana shares rise after insurer's medical costs came in lower than expected
▼ + stars: | 2023-08-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. Humana reported a medical loss ratio, the percentage of premiums it spends on medical care, of 86.3% for the second quarter. Humana highlighted a "stabilizing Medicare Advantage utilization environment" based on the most recent claims activity, without elaborating. The company said in June it expected its second-quarter medical loss ratio to be toward the top range of its full-year outlook of 86.3% to 87.3%. Shares are down about 5% for the year after the broader health-care sector took a beating in June, putting the company's market value at around $60 billion.

Persons: Humana Organizations: Humana, UnitedHealth

☆ Tenet Healthcare lifts annual forecast, bets on rebound in surgical procedures
▼ + stars: | 2023-07-31 | by ( ) www.reuters.com time to read: +2 min

July 31 (Reuters) - Tenet Healthcare Corp (THC.N) on Monday raised its annual core earnings forecast after a strong second quarter, betting on a recovery in surgical procedure volumes and improved contract labor costs as staffing shortage eases. The hospital operator sees its 2023 core earnings in the range of $3.31 billion to $3.46 billion, compared with its previous forecast of $3.2 billion to $3.4 billion. It expects adjusted profit per share in the range of $5.18 to $6.03 in 2023, compared with a prior forecast of $4.92 to $6.09. Larger rival, HCA Healthcare (HCA.N), the biggest for-profit hospital U.S. operator, also raised its full-year adjusted core earnings forecast to between $12.3 billion and $12.8 billion, from prior expectations of between $12.1 and $12.7 billion. On an adjusted basis, Tenet reported a net income of $1.44 per share for the quarter ended June, beating estimates of $1.25 per share.

Persons: Tenet, Sriparna Roy, Maju Samuel Organizations: Tenet Healthcare Corp, Tenet, UnitedHealth, HCA Healthcare, Thomson Locations: United States, U.S, Texas, Bengaluru

Major insurers UnitedHealth Group (UNH.N) and Humana (HUM.N) have already warned of booking higher costs due to a jump in non-urgent surgeries in the United States, highlighting demand for such procedures. HCA Healthcare, which is the biggest for-profit hospital operator in the United States, raised its full-year adjusted core earnings forecast to between $12.3 billion and $12.8 billion, from prior expectations of between $12.1 and $12.7 billion. "We anticipate the market wanted more even though HCA's outlook remains prudent as the healthcare system normalizes," said Citi analyst Jason Cassorla. Shares of rivals Tenet Healthcare (THC.N) and Universal Health Services (UHS.N) fell 2% and 1%, respectively, in morning trading. Profits at hospital operators took a hit following COVID-led lockdowns as people delayed non-urgent surgeries, and as the pandemic deepened a nursing shortage that led to a spike in costs.

Persons: Jason Cassorla, lockdowns, Khushi Mandowara, Manas Mishra, Shinjini Ganguli, Anil D'Silva Organizations: Healthcare Inc, UnitedHealth, HCA Healthcare, Citi, Tenet Healthcare, Universal Health Services, Thomson Locations: United States, Bengaluru

☆ The Dow just posted its best winning streak since the 1980s. Why it keeps going higher
▼ + stars: | 2023-07-26 | by ( Fred Imbert | ) www.cnbc.com time to read: +3 min

Brendan McDermid | ReutersThe Dow Jones Industrial Average just won't stop going higher it seems like. The Dow on Wednesday rose for a 13th straight day, matching its longest winning streak since 1987. Both are up just 3% since the Dow's streak began. There are several reasons for the Dow's streak, but none may be bigger than recession fears easing. Stock Chart Icon Stock chart icon Dow riding 12-day winning streakNo more recession?

Persons: Brendan McDermid, Dow, Steve Eisman, Neuberger Berman, CNBC's, Michael Lewis, Jerome Powell, Goldman Sachs, Johnson Organizations: New York Stock Exchange, Reuters, Dow Jones, Dow, Nasdaq, Federal, Companies, Goldman Sachs Group, Inc, UnitedHealth, JPMorgan Chase &, Johnson, Intel, CAT Caterpillar Inc Locations: New York City, U.S, Chevron

☆ Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen'
▼ + stars: | 2023-07-25 | by ( Patrick Wingrove | ) www.reuters.com time to read: +5 min

Seven drugmakers this month launched their own versions, known as biosimilars, of AbbVie's (ABBV.N) flagship arthritis drug Humira, once the world's top-selling prescription medicine. Three have kept their list price within 5%-7% of AbbVie's, two priced at an 85% discount and two have offered both types of prices. For insured patients who are often on the hook for co-pays of 10% to 25% of the list price, the savings have been minimal. Reuters GraphicsThe Biden administration has made lowering drug prices a priority. Amgen offered 5% and 55% discounts to AbbVie's $6,922 per month Humira price tag, and both were included on drug coverage lists at two large PBMs.

Persons: Dado Ruvic, Humira, Ameet Sarpatwari, Biden, PBMs, Cigna, UnitedHealth, Amgen, Robin Feldman, Ron Wyden, Wyden, Chuck Grassley, Grassley, Patrick Wingrove, Moira Warburton, Josephine Walker, Caroline Humer, Bill Berkrot Organizations: REUTERS, Association for Accessible Medicines, Harvard Medical School, Reuters, Lawmakers, Federal Trade Commission, FTC, CVS, Biosimilars, Healthcare, Novartis, Sandoz, Reuters Graphics Reuters, University California College of the, Democratic, Republican, Thomson Locations: U.S, Humira, San Francisco, New York, Washington

☆ CNBC Daily Open: Let’s talk about the Dow
▼ + stars: | 2023-07-24 | by ( Yeo Boon Ping | ) www.cnbc.com time to read: +5 min

Michael M. Santiago | Getty Images News | Getty ImagesThis report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. For the second half, the bank thinks GDP will grow 1.3%, compared with 0.6%. "India and China combined will make up 2 million barrels a day of demand pick-up in the second half of this year," he said. The bottom lineLet's talk about the Dow Jones Industrial Average and why it did better than the S&P 500 and the Nasdaq Composite last week.

Persons: Michael M, Tesla, Wood, Morgan Stanley, Joe Biden's, Ellen Zentner, Joseph McMonigle, McMonigle, Sarah Min, Dow, Goldman Sachs, Gamble Organizations: New York Stock Exchange, Santiago, Getty, CNBC, Nasdaq, KE Holdings, Joe Biden's Infrastructure Investment, Jobs, International Energy, Federal Reserve, Dow Jones Industrial, JPMorgan Chase, Apple, Microsoft, Nike, Procter, Nvidia, UnitedHealth, Dow Locations: New York City, China, U.S, India

As corporate earnings season reaches its peak in the coming weeks, Morgan Stanley advises traders to look for certain stock plays. Morgan Stanley chief equity strategist Mike Wilson said in a Monday note that he expects "performance dispersion to rise" as more companies report their earnings. Wilson recommends investors choose stocks that exhibit high earnings quality, strong free cash flow generation and improving earnings revision. Nonetheless, more than 90% of analysts covering the stock rate it a buy, according to Refinitiv. The company is set to report earnings Tuesday before the bell.

Persons: Morgan Stanley, Mike Wilson, Wilson, Morgan, Morgan Stanley's, Dara Mohsenian, — CNBC's Michael Bloom Organizations: Dow Jones, Microsoft, Chevron, ExxonMobil, Health, UnitedHealth, Humana, Elevance, Dow, Health Care, SDPR Fund, Mobile, General Motors, GM, Colgate, Palmolive, Comcast, CNBC Locations: U.S, NBCUniversal

☆ CNBC Daily Open: It’s time to talk about the Dow
▼ + stars: | 2023-07-24 | by ( Yeo Boon Ping | ) www.cnbc.com time to read: +3 min

Michael M. Santiago | Getty Images News | Getty ImagesThis report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. What you need to know todayThe bottom lineLet's talk about the Dow Jones Industrial Average and why it did better than the S&P 500 and the Nasdaq Composite last week. The S&P and the Dow were essentially flat, while the Nasdaq Composite lost 0.22% Friday. On a weekly basis, the S&P advanced 0.79%, the Nasdaq fell 0.57% — but the Dow gained an impressive 2.08%.

Persons: Michael M, Dow, Goldman Sachs, Gamble Organizations: New York Stock Exchange, Santiago, Getty, CNBC, Dow Jones Industrial, Nasdaq, JPMorgan Chase, Apple, Microsoft, Nike, Procter, Nvidia, UnitedHealth, Dow Locations: New York City

☆ This sleepy Dow ETF is gaining traction as the old-school average looks for a 10-day win streak
▼ + stars: | 2023-07-21 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

The Dow rose for the ninth consecutive trading session Thursday, its longest winning streak since 2017. Meanwhile, the SPDR Dow Jones Industrial Average (DIA) has raked in more than $1 billion in net inflows over the past week. Here are some other notable ETF data points from the past week. The fund has gained more than 4% this month and brought in about $300 million in new cash over the past week. SPY saw abnormally high outflows of more than $10 billion over the past week.

Persons: Dow, Goldman Sachs Organizations: Dow Jones, DIA, Trust, Big Tech, Microsoft, UnitedHealth, Vanguard, CSI China Internet

☆ Traders are wondering if now is the time for a summer market correction
▼ + stars: | 2023-07-21 | by ( Bob Pisani | ) www.cnbc.com time to read: +3 min

After a string of up days, the old market leadership of technology and consumer discretionary is looking tired, and that is probably a good thing. Since 1950, August is the third-worst month for the S & P 500, while September is the worst month. That is "historically extreme," Todd Sohn from Strategas told me, though it is consistent with coming off major market lows. A torrid two-month rally has lifted the S & P Technology Sector (XLK) by 16%, but tech has mostly been for sale in the last few days. Still, for investors in the S & P 500, McClellan says no one should be surprised to see a summer correction in the next month or so.

Persons: Tom McClellan, Nate Geraci, Schwab, Todd Sohn, Strategas, John Murphy, Banks, Murphy, UnitedHealth, Johnson, Abbott, Ed Yardeni, McClellan Organizations: The, Growth, P Technology, Microsoft, Apple, Nasdaq, NVIDIA, Meta, Technology, Health Care

☆ Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
▼ + stars: | 2023-07-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street's expectations, and lifted its full-year guidance as sales from the company's medtech business jumped. That compares with a net income of $4.8 billion, or $1.80 per share, for the same period a year ago. Excluding certain items, adjusted earnings per share were $2.80 for the period. J&J is now forecasting full-year sales of $98.80 billion to $99.80 billion, about $1 billion higher than the guidance provided in April. The company raised its 2023 adjusted earnings outlook to $10.70 to $10.80 per share, from a previous forecast of $10.60 to $10.70 per share.

Persons: Johnson Organizations: UnitedHealth, Elevance, Refinitiv

Abbott CEO Robert Ford said the great momentum in device and diagnostics sales during the quarter was due to improving market conditions in healthcare. Rival J&J's (JNJ.N) medical device segment also topped estimates, aided by a recovery in demand for medical procedures. Shares of rival medical device makers Medtronic (MDT.N) and Boston Scientific Corp (BSX.N) rose nearly 3%. Abbott clocked quarterly sales for its medical devices at $4.3 billion, with $1.3 billion coming from diabetes device Freestyle Libre, beating analysts' estimates of $4.10 billion. Abbott's adjusted profit of $1.08 per share in the quarter beat analysts' estimates of $1.05.

Persons: Robert Ford, J, Shagun Singh, Abbott, Khushi Mandowara, Pooja Desai Organizations: Abbott Laboratories, RBC Capital Markets, Boston Scientific Corp, U.S, Thomson Locations: Michigan, Bengaluru

☆ Bank results lift stocks; Dow up for seventh straight session
▼ + stars: | 2023-07-18 | by ( Chuck Mikolajczak | ) www.reuters.com time to read: +3 min

Shares of other banks such as Bank of New York Mellon (BK.N) and PNC Financial (PNC.N) also rose on Tuesday after they reported quarterly results. "I always hate to extrapolate the big bank earnings, which are always the first ones, to the rest of the market. The S&P 500 banks index (.SPXBK) advanced to its highest intraday level since March 10, when the start of a mini-bank crisis created a sharp sell-off in the sector. Charles Schwab (SCHW.N) shot higher as the best performer on the S&P 500 after the brokerage posted a smaller-than-expected drop in quarterly profit. Equities have rallied recently, with the S&P 500 and Nasdaq climbing to 15-month highs on data showing economic resilience, cooling inflation and a solid labor market.

Persons: Morgan Stanley, Tim Ghriskey, Ingalls & Snyder, JP Morgan, Charles Schwab, Bernstein, Chuck Mikolajczak, Richard Chang Organizations: Bank of America, Dow, Reuters Graphics Bank of America, Bank of New York Mellon, PNC Financial, PNC, Ingalls &, Nasdaq, Dow Jones, Technology, Microsoft, Thomson Locations: New York

☆ Here are Tuesday's biggest analyst calls: Apple, Alphabet, Pinterest, Netflix, Amazon, Nvidia & more
▼ + stars: | 2023-07-18 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Jefferies reiterates Apple as buy Jefferies said it's expecting a "quiet quarter" when the company reports earnings Aug. 3. Wells Fargo reiterates Netflix as overweight Wells said it's bullish heading into the company's earnings report Wednesday. Jefferies reiterates Alphabet as buy Jefferies said it's bullish heading into Alphabet earnings next week. Bank of America downgrades Lumentum to neutral from buy Bank of America called the stock an "overstated" AI beneficiary. JPMorgan reiterates Amazon as overweight JPMorgan said the e-commerce giant is its top pick heading into earnings. "

Persons: Jefferies, it's, Wells, Truist, Piper Sandler, Dave, Buster's, Piper, Bernstein, Goldman Sachs, Goldman, Max, Roth, Uber, Roth MKM, it's bullish, Morgan Stanley, Evercore, Marvell, Williams Deutsche, Sherwin Williams, JPMorgan Organizations: Apple, Netflix, Argus, Warner Brothers Discovery, Citi, Polaris Citi, 2Q, Bank of America, Nvidia, American Express, Digital, Marvell Technology Inc, Global, Inc, Deutsche Bank, Sherwin, JPMorgan Locations: capex

☆ UnitedHealth is worth buying and can rally nearly 25%, Bernstein says
▼ + stars: | 2023-07-18 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

UnitedHealth is worth buying as it still trades at a cheap valuation coming out of a good earnings report, according to Bernstein. Analyst Lance Wilkes upgraded the health insurance stock to outperform from market perform and raised his price target by $8 to $603. Now, he said those concerns are priced into the stock and valuation has fallen (from around 1.3 times earnings to 0.9 times earnings) to a level that undervalues the long-term growth opportunity. Despite the post-earnings rally, the Dow Jones Industrial Average member is still down nearly 9% in 2023 despite the broader market's rise. UnitedHealth trades at a 0.9 multiple relative to the S & P 500, near the Medicare-for-All lows of 0.85.

Persons: Bernstein, Lance Wilkes, Wilkes, UnitedHealth, That's, —, Michael Bloom Organizations: Dow Jones Industrial Locations: Monday's

☆ Stocks making the biggest moves midday: Morgan Stanley, Bank of America, Charles Schwab and more
▼ + stars: | 2023-07-18 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

Morgan Stanley — Shares of the James Gorman-led bank jumped more than 6% after the firm posted second-quarter earnings and revenue that topped analysts' expectations. Bank of America – Bank of America shares rose nearly 4% after the company reported second-quarter financial results. Bank of New York Mellon — Shares rose more than 4% after Bank of New York Mellon reported second-quarter revenue and profit that beat Wall Street's expectations. PNC Financial — Shares gained 2.6% after PNC Financial reported second-quarter earnings that topped Wall Street's earnings expectations but came in slightly short on revenue. The Swiss pharmaceutical firm reported second-quarter earnings that topped estimates, according to StreetAccount.

Persons: Charles Schwab, Morgan Stanley —, James Gorman, Morgan Stanley's, Refinitiv, PacWest, Bernstein, UnitedHealth, Pinterest, intraday, Masimo preannounced, Stifel, Lockheed Martin, Macheel, Sarah Min, Yun Li, Alex Harring, Michelle Fox Organizations: Bank of America – Bank of America, Regional Banking, Western Alliance, FB Financial, Verizon, AT, Bank of New York Mellon, PNC, PNC Financial, Novartis — U.S, Novartis, Sandoz, Masimo, Lockheed Locations: San Francisco , California, Swiss, FactSet

Search resuls for: "UnitedHealth"

25 mentions found